Clinical usefulness of nutraceutics with acetyl-L-carnitine, α-lipoic acid, phosphatidylserine, curcumin, C, E and B-group vitamins in patients awaiting for carpal tunnel release during COVID-19 pandemic: a randomized controlled open label prospective study

What Was Tested

The paper reports a study of L-Carnitine in the context of carpal tunnel, published as a randomized controlled trial.

Carpal Tunnel Syndrome (CTS) is provoked by the compression of the median nerve, leading to nerve ischemia, endoneural edema, venous congestion, and subsequent metabolic alterations.

Conservative treatments could be considered.

Who Took Part

The present investigation involved the outpatients who were planned to undergo open surgical decompression of the median nerve awaiting surgery from June 2020 and February 2021.

How the Study Was Run

In design terms this was a randomized study.

The participants were allocated by chance, so the L-Carnitine group and the comparison group should start out alike.

No major side effects were noticed.

What Was Measured

PubMed files the paper under topics including Carpal Tunnel Syndrome, Acetylcarnitine, Thioctic Acid, Vitamin B Complex, Curcumin, Phosphatidylserines and Pandemics.

What This Means in Plain Language

The paper is a randomized study of L-Carnitine in people with carpal tunnel.

Its findings take up roughly 2 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2023 (Acta bio-medica : Atenei Parmensis), a journal based in Italy.

More context: the L-Carnitine compound page, Carpal tunnel research.